“Interchangeability” of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy
2019 · Modern Pathology · 175 citations
https://doi.org/10.1038/s41379-019-0327-4
A
Andreas H. Scheel
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
167
Papers
4.0K
Citations
33
h-index
55
i10-index
Andreas H. Scheel is an academic researcher from University of Cologne. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & Peptidase Inhibition and Analysis. The author has an h-index of 33, co-authored 142 publications.
ORCID: 0000-0003-0244-1646Papers by this author
worksHER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer
2014 · Cell Death and Disease · 103 citations
https://doi.org/10.1038/cddis.2013.508
Evolutionary trajectories of small cell lung cancer under therapy
2024 · Nature · 94 citations
https://doi.org/10.1038/s41586-024-07177-7
Impact of updated HER2 testing guidelines in breast cancer—re-evaluation of HERA trial fluorescence in situ hybridization data
2015 · Modern Pathology · 60 citations
https://doi.org/10.1038/modpathol.2015.112
Talcum induced pneumoconiosis following inhalation of adulterated marijuana, a case report
2012 · Diagnostic Pathology · 42 citations
https://doi.org/10.1186/1746-1596-7-26
ALK G1269A mutation as a potential mechanism of acquired resistance to crizotinib in an ALK-rearranged inflammatory myofibroblastic tumor
2017 · npj Precision Oncology · 38 citations
https://doi.org/10.1038/s41698-017-0004-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat